- CEO of vaccine maker sold $10 million in stock before company ruined Johnson & Johnson doses https://www.washingtonpost.com/investigations/emergent-robert-kramer-stock-sales/2021/04/25/de151434-a2b6-11eb-a7ee-949c574a09ac_story.html 27 comments business
Linking pages
Linked pages
- Covid lawsuits weakened public health, U.S. pandemic preparedness - The Washington Post https://www.washingtonpost.com/health/2023/03/08/covid-public-health-backlash/ 65 comments
- White covid deaths increasing in U.S., surpassing death rate of Blacks - The Washington Post https://www.washingtonpost.com/health/2022/10/19/covid-deaths-us-race/ 16 comments
- U.S. Bet on Covid Vaccine Manufacturer Even as Problems Mounted - The New York Times https://www.nytimes.com/2021/04/06/us/covid-vaccines-emergent-biosolutions.html 4 comments
- Coronavirus map: Tracking cases in the U.S. and around the world - Washington Post https://www.washingtonpost.com/graphics/2020/world/mapping-spread-new-coronavirus/ 0 comments
Related searches:
Search whole site: site:www.washingtonpost.com
Search title: Vaccine maker Emergent's CEO sold $10 million in stock before company ruined Johnson & Johnson doses - The Washington Post
See how to search.